The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector easily access and use already available SIAPS resources, including tools, experiences, and results. The document is also intended to serve as a technical legacy for SIAPS to support knowledge exchange and sustainability of related work. … Read more
This policy guidance document is divided into 13 different areas: Country policy development Registration Planning Financing Revised program guidelines, Essential Medicines List (EML), and reporting and recording forms Training of health workers and community partners (community health worker/relais) ACSM strategies Forecasting and quantification Procurement Distribution Health system strengthening Quality and safety Monitoring and evaluation
The availability of a unified essential medicines list (EML) with evidence-based clinical efficacy to be used by the Ministry of Health (MOH) for the state-guaranteed package of services is an essential part of the successful launch of the health care reform initiative in Ukraine. This required the development and institutionalization of a process to ensure … Read more
The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program proposed a methodology for reviewing lists of essential medicines (LEM) and formularies, with the potential to achieve optimum results in short periods of time and with a minimal investment of resources. The methodology consisted of identifying an expert international pharmacologist with experience in the LEM process and the … Read more
This guide provides national stakeholders and advocates with information and guidance to update the national EML to include a new commodity, a new indication, or a new formulation based on the available evidence and based on country need and disease burden. While the actors, timeline, and process may vary from country to country, this guide … Read more
The Systems for Improving Access to Pharmaceuticals and Services (SIAPS) Program Mozambique has been working with DFH and partners in the pharmaceutical sector and in priority health programs to assist pharmaceutical services in improving the availability of pharmaceutical products and appropriate use at the service delivery points with the aim of achieving desired health outcomes. … Read more
Pharmaceuticals may constitute as much as 40% of the health care budget in low and middle-income countries, yet large portions of the population may lack access to even the most essential medicines. The limited public sector funds are frequently spent on ineffective or unnecessary medications. An analysis of past spending patterns on procurement of medicines … Read more
La Lista Nacional de Medicamentos Esenciales (LNME) de República Dominicana no se actualiza desde el año 2005. En el curso de 2012 y 2013 se revisaron algunos grupos terapéuticos y listas específicas de programas de control de enfermedades, como VIH y tuberculosis, pero no se consolidó y validó una lista nacional. En mayo del 2014 … Read more
The National Essential Medicines List (NEML) of the Dominican Republic had not been updated since 2005. Over the course of 2012 and 2013, some therapeutic groups and specific lists of disease control programs, such as HIV and tuberculosis, were revised, but they were not consolidated and validated as a national list. In May 2014 the … Read more
In South Africa, the provision of pharmaceutical services is guided by the National Drug Policy (NDP), which was adopted in 1996. The health goal of the NDP is ―to ensure the availability and accessibility of essential medicines to all citizens. Within a resource-constrained environment, irrational medicine use has the potential to compromise available health care … Read more
